Current and Future Directions in Genomics of Amyotrophic Lateral Sclerosis

Physical Medicine and Rehabilitation Clinics of North America

Volumn 19, Issue 3, 2008, Pages 461-477

  Ravits, John ^a,b,c   Traynor, Bryan J ^d  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b BENAROYA RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; CODING; DNA FINGERPRINTING; EPIGENETICS; EXON; FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS; GENE CONTROL; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HAPLOTYPE MAP; HUMAN; HUMAN GENOME PROJECT; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPORADIC AMYOTROPHIC LATERAL SCLEROSIS;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; GENE EXPRESSION; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOMICS; HUMANS; RNA;

EID: 46749106723     PISSN: 10479651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmr.2008.04.001     Document Type: Review

References (77)

1. Figlewicz D.A., and Orrell R.W. The genetics of motor neuron disease. Amyotroph Lateral Scler Other Motor Neuron Disord 4 (2003) 225-231
2. Valdmanis P.N., and Rouleau G.A. Genetics of familial amyotrophic lateral sclerosis. Neurology 70 (2008) 144-152
3. Andersen P.M. Amyotrophic lateral sclerosis associated with mutations in the Cu Zn superoxide dismutase gene. Curr Neurol Neuroscie Rep 6 (2006) 37-46
4. Simpson C.L., and Al-Chalabi A. Amyotrophic lateral sclerosis as a complex genetic disease. Biochim Biophys Acta 1762 (2006) 973-985
5. Novoyatleva T., Tang Y., Rafalska I., et al. Pre-mRNA missplicing as a cause of human disease. Prog Mol Subcell Biol 44 (2006) 27-46
6. Johnson J.M., Edwards S., Shoemaker D., et al. Dark matter in the genome: evidence of widespread transcription detected by microarray tiling experiments. Trends Genet 21 2 (2005) 93-102
7. The International HapMap Consortium. A haplotype of the human genome. Nature 437 (2005) 1299-1320
8. Barnes M.R. Navigating the HapMap. Brief Bioinform 7 (2006) 211-224
9. Hartyl D.L., and Clark A.G. Principles of population genetics. 4th edition (2007), Sinauer Associates, Inc., Sunderland (MA) p. 652
10. Abecasis G.R., Ghosh D., and Nichols T.E. Linkage disequilibrium: ancient history drives the new genetics. Hum Hered 59 (2005) 118-124
11. Brown P.O., and Botstein D. Exploring the new world of the genome with DNA microarrays. Nat Genet 21 1 Suppl (1999) 33-37
12. Goodman L. Hypothesis-limited research. Genome Res 9 (1999) 673-674
13. In: Barnes M.R. (Ed). Bioinformatics for geneticists. A bioinformatics primer for the analysis of genetic data. 2nd edition (2007), Wiley and Sons, West Sussex (England) 554
14. Hirschhorn J.M., and Daly M.J. Genome-wide association studies for complex diseases and complex traits. Nat Rev Genet 6 (2005) 95-108
15. Balding D.J. A tutorial on statistical methods for population association studies. Nat Rev Genet 7 (2006) 781-791
16. Reich D.E., and Lander E.S. On the allelic spectrum of human disease. Trends Genet 17 (2001) 502-510
17. Pritchard J.K. Are rare variants responsible for susceptibility to complex diseases?. Am J Hum Genet 69 (2001) 124-137
18. Terwilliger J.D., and Hiekkalinna T. An utter refutation of the fundamental theorem of the HapMap. Eur J Hum Genet 14 (2006) 426-437
19. Wright A.F., and Hastie N.D. Complex genetic diseases: controversy over the Croesus code. Genome Biol 2 8 (2001) [comment/2007]
20. Schymick J., Scholz S.W., Fung H.-C., et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls. Lancet Neurol 6 4 (2007) 322-328
21. Dunckley T., Huentelman M.J., Craig D.W., et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. NEJM 357 (2007) 1-14
22. van Es M.A., van Vught P.W., Blauw H.W., et al. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol 6 10 (2007) 869-877
23. Cronin S., Berger S., Ding J., et al. A genome-wide association study of sporadic ALS in a homogenous Irish population. Hum Mol Genet 17 (2008) 768-774
24. van Es M.A., van Vught P.W., Blauw H.M., et al. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat Genet 40 1 (2008) 29-31
25. Garber K. The elusive ALS genes. Science 319 5859 (2008) 20
26. Skol A.D., Scott L.J., Abecasis G.R., et al. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat Genet 38 (2006) 209-213. http://www.sph.umich.edu/csg/abecasis/CaTS/index.html Available at:
27. Kirby J., Heath P.R., Shaw P.J., et al. Gene expression assays. Adv Clin Chem 44 (2007) 247-292
28. Li J., Schwartz S.M., and Bumgarner R.E. RNA amplification, fidelity and reproducibility of expression profiling. Comptes Rendus Biol 326 (2003) 1021-1030
29. Ginsberg S.D., and Che S. RNA amplification in brain tissues. Neurochem Res 27 (2002) 981-992
30. Kelz M.B., Dent G.W., Therlanos S., et al. Single-cell antisense RNA amplification and microarray analysis as a tool for studying neurological degeneration and restoration. Sci Aging Knowledge Environ 1 (2002) 1-10
31. In: Speed T. (Ed). Statistical analysis of gene expression microarray data (2003), Chapman and Hall/CRC Press LLC, Boca Raton (FL) 1-222
32. Subramanian A., Tamayo P., Mootha V., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102 (2005) 15545-15550
33. Bild A., and Febbo P.G. Application of a priori established gene sets to discover biologically important differential expression in microarray data. Proc Natl Acad Sci U S A 1073 (2005) 15278-15279
34. Efron B., and Tibshirani R. On testing the significance of sets of genes. Available at:. http://www-stat.stanford.edu/∼tibs/ftp/GSA.pdf
35. Emmert-Buck M.R., Bonner R.F., Smith P.D., et al. Laser capture microdissection. Science 274 (1996) 998-1001
36. Bonner R.F., Emmert-Buck M., Cole K., et al. Laser capture microdissection: molecular analysis of tissue. Science 278 (1997) 1481-1483
37. Nisenbaum L.K. The ultimate chip shot: can microarray technology deliver for neuroscience?. Genes Brain Behav 1 (2002) 27-34
38. Mills J.C., Roth K.A., Cagan R.L., et al. DNA microarrays and beyond: completing the journey from tissue to cell. Nat Cell Biol 3 (2001) E175-E178
39. Ravits J., Paul P., and Jorg C. Focality of upper and lower motor neuron degeneration at the clinical onset of ALS. Neurology 68 (2007) 1571-1575
40. Ravits J., Laurie P., Fan Y., et al. Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem. Neurology 68 (2007) 1576-1582
41. Ravits J., Laurie P., and Stone B. Amyotrophic lateral sclerosis microgenomics. Phys Med Rehabil Clin N Am 16 4 (2005) 909-924
42. Kacharmina J.E., Crino P.B., and Eberwine J. Preparation of cDNA from single cells and sub cellular regions. Methods Enzymol 303 (1999) 3-18
43. Crino P.B., Trojanowski J.Q., Dichter M.A., et al. Embryonic neuronal markers in tuberous sclerosis: single-cell molecular pathology. Proc Natl Acad Sci USA 93 (1996) 14152-14157
44. Humphery-Smith I., Cordwell S.J., and Blackstock W.P. Proteome research: complementarity and limitations with respect to the RNA and DNA worlds. Electrophoresis 18 (1997) 1217-1242
45. Greenbaum D., Colangelo C., Williams K., et al. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol 4 9 (2003) 117
46. Heath P.R., Tomkins J., Ince P.G., et al. Quantitative assessment of AMPA receptor mRNA in human spinal motor neurons isolated by laser capture microdissection. Neuroreport 13 14 (2002) 1753-1757
47. Mawrin C., Kirches E., and Dietzmann K. Single-cell analysis of mtDNA in amyotrophic lateral sclerosis: towards the characterization of individual neurons in neurodegenerative disorders. Pathol Res Pract 199 (2003) 415-418
48. Malaspina A., Kaushik N., and de Belleroche J. Differential expression of 14 genes in amyotrophic lateral sclerosis spinal cord detected using gridded cDNA arrays. J Neurochem 77 (2001) 132-145
49. Ishigaki S., Niwa J., Ando Y., et al. Differentially expressed genes in sporadic amyotrophic lateral sclerosis spinal cords-screening by molecular indexing and subsequent cDNA microarray analysis. FEBS Lett 531 (2002) 354-358
50. Dangond F., Hwang D., Camelo S., et al. Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter. Physiol Genomics 16 (2004) 229-239
51. Olsen M.K., Roberds S.L., Ellerbrock B.R., et al. Disease mechanisms revealed by transcription profiling in SOD1-G93A transgenic mouse spinal cord. Ann Neurol 50 (2001) 730-740
52. Yoshihara T., Ishigaki S., Yamamoto M., et al. Differential expression of inflammation- and apoptosis-related genes in spinal cords of a mutant SOD1 transgenic mouse model of familial amyotrophic lateral sclerosis. J Neurochem 80 (2002) 158-167
53. Hensley K., Floyd R.A., Gordon B., et al. Temporal patterns of cytokine and apoptosis-related gene expression in spinal cords of the G93A-SOD1 mouse model of amyotrophic lateral sclerosis. J Neurochem 82 (2002) 365-374
54. Jiang Y.-M., Yamamoto M., Koyayashi Y., et al. Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol 57 (2005) 236-251
55. Perrin F., Boisset G., Docquier M., et al. No widespread induction of cell death genes occurs in pure motoneurons in an amyotrophic lateral sclerosis mouse model. Hum Mol Genet 14 (2005) 3309-3320
56. Lobsiger C.S., Boillee S., and Cleveland D.W. Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons. Proc Natl Acad Sci U S A 104 (2007) 7319-7326
57. Ferraiuolo L., Heath P.R., Holden H., et al. Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS. J Neurosci 27 (2007) 9201-9219
58. Jiang Y.M., Yamamoto M., Tanaka F., et al. Gene expression specifically detected in motor neurons (dynactin 1, early growth response 3, acetyl-CoA transporter, death receptor 5, and cyclin C) differentially correlate to pathologic markers in sporadic amyotrophic lateral sclerosis. J Neuropthol Exp Neurol 66 (2007) 617-627
59. Cuperlovic-Culf M., Belacel N., Culf A.S., et al. Microarray analysis of alternative splicing. OMICS 10 3 (2006) 344-357
60. Clark T.A., Schweitzer A.C., Chen T.X., et al. Discovery of tissue-specific exons using comprehensive human exon microarrays. Genome Biol 8 4 (2007) R64 1-16
61. Heinzen E.L., Yoon W., Weale M.E., et al. Alternative ion channel splicing in mesial temporal lobe epilepsy and Alzheimer's disease. Genome Biol 8 3 (2007) R32 1-18
62. Newmann M., Sampathu D.M., Kwong L.K., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 5796 (2006) 130-133
63. Arai T., Hasegawa L.M., Akiyama H., et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351 (2006) 602-611
64. Buratti E., Dork T., Zuccato E., et al. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J 20 7 (2001) 1774-1784
65. Krichevsky A.M. MicroRNA profiling: from dark matter to white matter, or identifying new players in neurobiology. ScientificWorldJournal 7 S2 (2007) 155-166
66. Kim V.N., and Nam J.-W. Genomics of microRNA. Trends Genet 22 (2005) 165-173
67. Mehler M.F., and Mattick J.S. Non-coding RNAs in the nervous system. J Physiol 575 (2006) 333-341
68. Nelson P.T., and Keller J.N. RNA in brain disease: no longer just "the messenger in the middle". J Neuropathol Exp Neurol 66 (2007) 461-468
69. Mockler T.C., and Ecker J.R. Applications of DNA tiling arrays for whole-genome analysis. Genomics 85 (2005) 1-15
70. Hoheisel J. Microarray technology: beyond transcript profiling and genotype analysis. Nat Rev Genet 7 (2006) 200-210
71. Cowell J.K., and Hawthorn L. The application of microarray technology to the analysis of the cancer genome. Curr Mol Med 7 (2007) 103-120
72. Chaudhuri K., and Chatterjee R. MicroRNA detection and target prediction: integration of computational and experimental approaches. DNA Cell Biol 26 (2007) 321-337
73. Berezikow E., Cuppen E., and Plasterek R.H. Approaches to microRNA discovery. Nat Genet 38 (2006) 52-57
74. Zhang B., Pan X., Wang Q., et al. Computational identification of microRNAs and their targets. Comput Biol Chem 30 (2006) 395-407
75. Huang J.C., Morris Q.D., and Frey B.J. Bayesian inference of microRNA targets from sequence and expression data. J Comput Biol 14 (2007) 550-563
76. Saetrom P., Snøve Jr. O., and Rossi J.J. Epigenetics and microRNA. Pediatr Res 61 (2007) 17R-23R
77. Chuang J.C., and Jones P.A. Epigenetics and microRNA. Pediatr Res 61 (2007) 24R-29R